`571-272-7822
`
` Paper No. 4
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`AMNEAL PHARMACEUTICALS LLC and AMNEAL
`PHARMACEUTICALS OF NEW YORK, LLC,
`Petitioner,
`
`v.
`
`ALMIRALL, LLC,
`Patent Owner.
`____________
`
`Case IPR2019-00207
`Patent 9,517,219
`____________
`
`Mailed: November 14, 2018
`
`Before PAULA CONN, Trial Paralegal
`
`
`NOTICE OF FILING DATE ACCORDED TO PETITION
`AND
`TIME FOR FILING PATENT OWNER PRELIMINARY RESPONSE
`
`The petition for inter partes review, filed in the above proceeding has
`been accorded the filing date of November 6, 2018.
`Patent Owner may file a preliminary response to the petition no later
`than three months from the date of this notice. The preliminary response is
`limited to setting forth the reasons why the requested review should not be
`instituted. Patent Owner may also file an election to waive the preliminary
`
`
`
`Case IPR2019-00207
`Patent No. 9,517,219
`
`response to expedite the proceeding. For more information, please consult
`the Office Patent Trial Practice Guide, 77 Fed. Reg. 48756 (Aug. 14, 2012),
`which is available on the Board Web site at http://www.uspto.gov/PTAB.
`Patent Owner is advised of the requirement to submit mandatory
`notice information under 37 C.F.R. § 42.8(a)(2) within 21 days of service of
`the petition.
`The parties are encouraged to use the heading on the first page of this
`Notice for all future filings in the proceeding.
`The parties are advised that under 37 C.F.R. § 42.10(c), recognition of
`counsel pro hac vice requires a showing of good cause. The parties are
`authorized to file motions for pro hac vice admission under 37 C.F.R.
`§ 42.10(c). Such motions shall be filed in accordance with the “Order --
`Authorizing Motion for Pro Hac Vice Admission” in Case IPR2013-00639,
`Paper 7, a copy of which is available on the Board Web site under
`“Representative Orders, Decisions, and Notices.”
`The parties are reminded that unless otherwise permitted by 37 C.F.R.
`§ 42.6(b)(2), all filings in this proceeding must be made electronically in the
`Patent Review Processing System (PRPS), accessible from the Board Web
`site at http://www.uspto.gov/PTAB. To file documents, users must first
`obtain a user ID and password by registering with PRPS. Information
`regarding how to register with and use PRPS is available at the Board Web
`site.
`
`If there are any questions pertaining to this notice, please contact
`Paula Conn at 571-272-4589 or the Patent Trial and Appeal Board at
`571-272-7822.
`
`
`
`
`2
`
`
`
`Case IPR2019-00207
`Patent No. 9,517,219
`
`PETITIONER:
`
`Dennies Varughese, Pharm. D.,
`Adam C. LaRock
`STERNE, KESSLER, GOLDSTEIN & FOX
`Dvarughe-PTAB@skgf.com
`Alarock-PTAB@skgf.com
`
`
`PATENT OWNER:
`
`Allergan, INC.
`2525 Dupont Drive, T2-7H
`Irvine CA 92612-1599
`
`
`
`
`
`3
`
`